SCHEMBL9067330

SCHEMBL9067330

C[C]C1(C)CCCc2ccccc21

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.53
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SIGMAR1 Q99720 11/20 0.44
EBP Q15125 1/20 0.43
TSHR P16473 2/20 0.43
TP53 P04637 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
DRD2 P14416 1/20 0.42
NFKB1 P19838 1/20 0.42
HTR2A P28223 1/20 0.42
HTR2C P28335 1/20 0.42
MAPK1 P28482 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTR2B P41595 1/20 0.42
MTOR P42345 1/20 0.42
AKR1B1 P15121 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20136589 0.84 KDM1A (0.51) KDM1AMEN1KMT2ASIGMAR1EBP
SCHEMBL779686 0.84 KDM1A (0.51) KDM1AMEN1KMT2ASIGMAR1EBP
SCHEMBL29556050 0.76 KDM1A (0.59) KDM1AMEN1KMT2ASIGMAR1EBP
SCHEMBL578812 0.76 KDM1A (0.59) KDM1AMEN1KMT2ASIGMAR1EBP
SCHEMBL7213608 0.75 KDM1A (0.53) KDM1AMEN1KMT2ASIGMAR1TSHR
Ammonia Solution, Strong SCHEMBL27728989 0.75 KDM1A (0.58) KDM1AMEN1KMT2ASIGMAR1EBP
SCHEMBL24124824 0.73 KDM1A (0.56) KDM1AMEN1KMT2ASIGMAR1EBP
SCHEMBL643388 0.73 KDM1A (0.66) KDM1AMEN1KMT2ASIGMAR1EBP
SCHEMBL1273553 0.73 KDM1A (0.66) KDM1AMEN1KMT2ASIGMAR1EBP
SCHEMBL6689565 0.73 KDM1A (0.56) KDM1AMEN1KMT2ASIGMAR1EBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150291728-A1 EPOXY COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE EPOXY RESIN COMPOSITION DAICEL CORPORATION (JP) 2015-10-15 US disclosed
EP-2921513-A1 EPOXY COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE EPOXY RESIN COMPOSITION Daicel Corporation (JP) 2015-09-23 EP disclosed
US-5502207-A ALKENYL-SUBSTITUTED BISNADIMIDE MARUZEN PETROCHEMICAL CO., LTD. (JP) 1996-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150291728-A1 EPOXY COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE EPOXY RESIN COMPOSITION CBR1, SEM1, EEF1A1 KDM1A 45/4885MEN1 2699/4885KMT2A 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.